CIK 0001750284
- Non-accelerated filer
- Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 300409740
- Phone
- +1 415-651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 17 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-04 | Mitchell Shawnte CHIEF LEGAL OFFICER | Option exercise | +25,000 | $4.37 | $109K | 25,000 |
| 2026-03-04 | Mitchell Shawnte CHIEF LEGAL OFFICER | Sale | −24,767 | $24.25 | $601K | 233 |
| 2026-03-04 | Mitchell Shawnte CHIEF LEGAL OFFICER | Sale | −233 | $24.69 | $6K | 0 |
| 2026-03-04 | Mitchell Shawnte CHIEF LEGAL OFFICER | Option exercise · Stock Option (Right to Buy) | −25,000 | 410,000 | ||
| 2026-03-03 | Mitchell Shawnte CHIEF LEGAL OFFICER | Option exercise | +15,000 | $4.37 | $66K | 15,000 |
| 2026-03-03 | Mitchell Shawnte CHIEF LEGAL OFFICER | Sale | −15,000 | $23.01 | $345K | 0 |
| 2026-03-03 | Mitchell Shawnte CHIEF LEGAL OFFICER | Option exercise · Stock Option (Right to Buy) | −15,000 | 435,000 | ||
| 2026-02-02 | Mitchell Shawnte CHIEF LEGAL OFFICER | Grant or award · Stock Option (Right to Buy) | +220,000 | 220,000 | ||
| 2026-02-02 | Mitchell Shawnte CHIEF LEGAL OFFICER | Grant or award · Performance Stock Options (Right to Buy) | +56,250 | 56,250 | ||
| 2025-02-28 | Mitchell Shawnte CHIEF LEGAL OFFICER | Grant or award · Stock Option (Right to Buy) | +450,000 | 450,000 |
Page 1 of 1 · 10 trades